Literature DB >> 10599446

Urothelial differentiation and bladder cancer.

M Liebert1, D Gebhardt, C Wood, I L Chen, J Ellard, D Amancio, H B Grossman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10599446     DOI： 10.1007/978-1-4615-4737-2_34

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  4 in total

1.  Loss of 15-hydroxyprostaglandin dehydrogenase expression disrupts urothelial differentiation.

Authors:  Stephanie Tseng-Rogenski; I-Ling Lee; Daniel Gebhardt; Susan M Fischer; Christopher Wood; John M Park; Monica Liebert
Journal:  Urology       Date:  2008-02       Impact factor: 2.649

Review 2.  Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis.

Authors:  Sarah E Daugherty; Ruth M Pfeiffer; Alice J Sigurdson; Richard B Hayes; Michael Leitzmann; Arthur Schatzkin; Albert R Hollenbeck; Debra T Silverman
Journal:  Am J Epidemiol       Date:  2011-03-02       Impact factor: 4.897

Review 3.  [Non-invasive urinary diagnosis of bladder cancer. What do we know?].

Authors:  I Kausch; A Böhle
Journal:  Urologe A       Date:  2003-04-11       Impact factor: 0.639

4.  Can daily intake of aspirin and/or statins influence the behavior of non-muscle invasive bladder cancer? A retrospective study on a cohort of patients undergoing transurethral bladder resection.

Authors:  Antonio Pastore; Giovanni Palleschi; Andrea Fuschi; Luigi Silvestri; Yazan Al Salhi; Elisabetta Costantini; Alessandro Zucchi; Vincenzo Petrozza; Cosimo de Nunzio; Antonio Carbone
Journal:  BMC Cancer       Date:  2015-03-13       Impact factor: 4.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.